0001179110-19-005766.txt : 20190509 0001179110-19-005766.hdr.sgml : 20190509 20190509162415 ACCESSION NUMBER: 0001179110-19-005766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190507 FILED AS OF DATE: 20190509 DATE AS OF CHANGE: 20190509 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WHEELER CRAIG A CENTRAL INDEX KEY: 0001229450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50797 FILM NUMBER: 19810918 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001235010 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 043561634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 491-9700 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 edgar.xml FORM 4 - X0306 4 2019-05-07 0 0001235010 MOMENTA PHARMACEUTICALS INC MNTA 0001229450 WHEELER CRAIG A C/O MOMENTA PHARMACEUTICALS, INC. 301 BINNEY STREET CAMBRIDGE MA 02142 1 1 0 0 President & CEO Common Stock 2019-05-07 4 M 0 5781 A 21531 D Common Stock 2019-05-08 4 S 0 2601 13.98 D 18930 D Common Stock 390719 I Craig Wheeler Revocable Trust Common Stock 36725 I Craig A Wheeler 2016 Annuity Trust Common Stock 60000 I Craig A Wheeler 2018 Annuity Trust Restricted Stock Units 2019-05-07 4 M 0 5781 0 D Common Stock 5781 40469 D Shares received pursuant to settlement of Restricted Stock Units that were granted on February 7, 2017. Restricted Stock Units convert into common stock on a one-for-one basis. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person August 7, 2017. This transaction was executed in multiple trades at prices ranging from $13.67 to $14.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Subject to the officer's continued employment with the company, the restricted stock units will vest with respect to 25% of the shares on the first anniversary of the grant date, and the remainder will vest in equal quarterly installments over the subsequent three years. /s/ R. Mark Chamberlin as attorney in fact 2019-05-09